P von Hoegen - JoVE Visualize

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

International Journal of Cancer|April 15, 1986

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effectsR Heicappell, V Schirrmacher, P von Hoegen, et al.

European Journal of Immunology|October 1, 1993

Viral hemagglutinin augments peptide-specific cytotoxic T cell responsesC Ertel, N S Millar, P T Emmerson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996

Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasisM Rocha, A Krüger, V Umansky, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic miceV Schirrmacher, P von Hoegen, A Griesbach, et al.

The Journal of Experimental Medicine|December 1, 1989

Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridomaP von Hoegen, M C Miceli, B Tourvieille, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998

Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistanceV Schirrmacher, U Beutner, M Bucur, et al.

International Journal of Cancer|March 16, 1995

Promotion of experimental liver metastasis by tumor necrosis factorP Orosz, A Krüger, M Hubbe, et al.

Blood|November 1, 1994

Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphomaA Krüger, V Umansky, M Rocha, et al.

American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|May 17, 2003

Proteomic prediction of disease outcome in cancer : clinical framework and current statusR Steinert, P von Hoegen, L M Fels, et al.

Gene Therapy|August 3, 2000

Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokineV Schirmacher, P Förg, W Dalemans, et al.

Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

International Journal of Cancer|April 15, 1986

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effectsR Heicappell, V Schirrmacher, P von Hoegen, et al.

European Journal of Immunology|October 1, 1993

Viral hemagglutinin augments peptide-specific cytotoxic T cell responsesC Ertel, N S Millar, P T Emmerson, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996

Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasisM Rocha, A Krüger, V Umansky, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1991

Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic miceV Schirrmacher, P von Hoegen, A Griesbach, et al.

The Journal of Experimental Medicine|December 1, 1989

Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridomaP von Hoegen, M C Miceli, B Tourvieille, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998

Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistanceV Schirrmacher, U Beutner, M Bucur, et al.

International Journal of Cancer|March 16, 1995

Promotion of experimental liver metastasis by tumor necrosis factorP Orosz, A Krüger, M Hubbe, et al.

Blood|November 1, 1994

Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphomaA Krüger, V Umansky, M Rocha, et al.

American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|May 17, 2003

Proteomic prediction of disease outcome in cancer : clinical framework and current statusR Steinert, P von Hoegen, L M Fels, et al.

Gene Therapy|August 3, 2000

Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokineV Schirmacher, P Förg, W Dalemans, et al.

Pageof 4